Search
for
Sort by
Research 61–90 of 1000+
- Psoriasis and Related Disorders
- Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
- Holistic Ayurvedic Management of Psoriasis with special reference to Eka Kustha
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- 169 Clinical features, etiologic factors, treatment, and comorbidities of palmoplantar pustulosis: a retrospective single-center study
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Scalp Psoriasis
- Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Adalimumab‐induced scalp psoriasis with severe alopecia
- An Update on Scalp Psoriasis
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- 071 Creating Value for Psoriasis Patients: Development of a patient-driven Outcome Set for Clinical Practice
- Hair Trichology Treatment
- Alopecia areata, morphea and psoriasis
- Videodermoscopy of the hyponychium in nail bed psoriasis
- Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
- Treatment of Generalized Lichen Planus With Alefacept
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Diseases of the skin. Treatment of scalp disorders.
- Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Nanoemulgels: A new approach for the treatment of skin-related disorders